chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A large rash appeared on the fourth day, about 3-4 in in diameter just below the injection site.  It was raised like a hive, had a local fever, and felt sore like a bruise.  It lasted for about 5 days before it disappeared.  The day after the vaccine I got the expected fever, chills and fatigue and that all went away by the next day.  I did have Covid-19 in October so I am assuming the fever, chills, and fatigue were because I had antibodies still in my body.
Nausea, emesis, fever, dizziness, cough, lasted for 5 days. self resolving.
My arm became hard, painful and red, during the night and I lost my mobility. I went to employee health at 7:30 am on 8/1/2013 and was seen they told me to monitor it use ice that it was a severve local reaction. I monitored it and spoke with several MD's on my unit. At approximately 12:00 it continued to swell and become redder and spread. I had marked it with marking pen to keep track. Spoke with DR and she call in antibiotic because I was told by one of the MD's that it looked like cellulitis. I left work at 3:30 pm picked up my med and went home. Took picture at home to seen to my husband who is an emergency room physician. The redness had continued down my arm to my forearm and had completely wrapped itself around my arm. My arm was now 2 times the size normally. The swelling and pain had also spread to my back and shoulder and up my neck, which caused swelling of my lymph nodes. My husband told me to go to the emergency room at his hospital and he called ahead to tell them I was on my way I leave 3 minutes from the hospital. I was taken straight back and treated for a severe allergic reaction and for rapid spreading cellulitis. I was kept in the emergency room and monitored until approximately 3:00 am on Friday 8/2/2013. I was prescribed Clindamycin and Prednisone to continue taking at home. I was then released into my husbands care. I have contacted employee health, my primary care physician's office, and Risk Management at work.
No adverse effects; Received improperly stored ROTATEQ; This spontaneous report was received from a medical assistant refers to a patient of an unknown age and gender. The patient's pertinent medical history, concomitant medication and drug reactions or allergies were not reported.  On 19-JUN-2019, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # R025731 (expiry date: 14-JUN-2020) for prophylaxis (strength, anatomical location, route and dosage details were not reported) (Product storage error). The vaccine was stored at a highest temperature above 47 degree Fahrenheit (F)/ 9 degree Centigrade (46.5F) for a time frame of 30 minutes. The patient did not experience any adverse effects. There was no previous temperature excursion. The call was because of a "data logger". No product quality complaint (PQC) was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA009509: US-009507513-1906USA009082: US-009507513-1906USA009522: US-009507513-1906USA009513: US-009507513-1906USA009514:
FELT FATIGUE; SHORTNESS OF BREATH; BLURRY VISION; HEART PALPITATIONS; DIZZINESS; VACCINATION SITE IS HARD THE SIZE OF A SILVER DOLLAR; SWEATING PROFUSELY; DIFFICULTY GOING UP THE STAIRS; WEAKNESS LIKE PASSING OUT; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced shortness of breath. On APR-2021, the subject experienced blurry vision. On APR-2021, the subject experienced heart palpitations. On APR-2021, the subject experienced dizziness. On APR-2021, the subject experienced vaccination site is hard the size of a silver dollar. On APR-2021, the subject experienced sweating profusely. On APR-2021, the subject experienced difficulty going up the stairs. On APR-2021, the subject experienced weakness like passing out. On APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 102 F. On 11-APR-2021, the subject experienced felt fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the felt fatigue, fever, blurry vision, heart palpitations, dizziness, weakness like passing out, shortness of breath, vaccination site is hard the size of a silver dollar, sweating profusely and difficulty going up the stairs was not reported. This report was non-serious.; Sender's Comments: V.0 Medical assessment comment not required as per standard procedure as case was assessed as non-serious.
FLU, despite having had the flu vaccine.  Fever, sore throat, cough, loss of appetite, extreme fatigue.  Have had the seasonal flu vaccine every year since 2006 (16 years), and have never gotten the flu before.
Injection was in upper left shoulder muscle.  Very painful from the beginning and pain got worse and arm was black and blue for 2 weeks after injection was given.  The second injection was given 4 months later in the right upper shoulder muscle with same painful  symptoms along with rash in the area of muscle down to elbow.
She also has runny nose; her left neck is also achy since monday; Patient left arm has been achy since the vaccine on monday; This is a spontaneous report from a contactable consumer reported for a patient. A 30-year-old female patient (no pregnant) received her dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/lot number: EH9899), via an unspecified route of administration in Left arm on 21Dec2020 11:45 at single dose for COVID-19 immunization. Medical history was none. The patient's concomitant medications were not reported. The patient experienced left arm had been achy since the vaccine on Monday and her left neck was also achy since Monday on 21Dec2020 11:45 AM. She also had runny nose on 21Dec2020 11:45 AM. No treatment received for the events. The events were reported as non-serious. The most recent COVID-19 vaccine was administered in hospital. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was unknown.
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Congestive heart failure. Concomitant products included DIGOXIN and SPIRONOLACTONE (ALDACTONE [SPIRONOLACTONE]) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.            No treatment medications were provided.  The patient experienced dizziness, she states the whole room spins only when she is going to bed at night, but the dizziness is not there in the morning.  The action taken with mRNA-1273 in response to the event was not applicable.
Medical assistant calling to report a temperature excursion that occurred 8/14/2020 which involved the following products: GARDASIL9, PEDVAXHIB, RECOMBIVAX, ROTATEQ. Per caller, "it would be possible that at least 100 patients have received vaccines; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies or concomitant medications were not reported.  On 17-AUG-2020, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) as prophylaxis (lot # S036818 with expiration date 22-APR-2022) (strength, frequency, route of administration and anatomical location were not reported).  The improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) experienced a temperature excursion of 35.4 Fahrenheit degrees (°F) for the time frame of 20 minutes without previous temperature excursions. It was confirmed that a digital data logger was involved.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2009USA006106:
Information has been received from a Pharmacist concerning a male who on 16-SEP-2012 was inadvertently administered an expired dose of PNEUMOVAX 23 (lot #0595AA, exp date 30AUG12). No adverse effect was reported. Additional information has been requested.
Patient has large raised lied down with few blister like areas. Patient outlined areas and cool compress and IBU 400mg. Temp 98.
This spontaneous report was received from a pharmacist and refers to a male patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, approximately in 2017 (reported as "within the "last two months"), the patient was vaccinated with ZOSTAVAX one injection (route of administration, lot# and expiration dose were not reported) for prophylaxis and influenza virus vaccine (unspecified) at the same time. On an unknown date, approximately in 2017 (reported as "after getting both vaccinations at the same time"), the patient experienced feeling run-down, tired and very sick. The outcome of the events and causality assessment was not provided.
Day after and following day-fever, joint and muscle pain.   Muscle pain and joint stiffness still effecting me 16 days after shot.
PATIENT EXPERIENCED FATIGUE FROM THE DAY OF THE VACCINATION AND REPORTED THAT SHE CONTINUES TO FEEL FATIGUED. SHE SAYS THAT THE FATIGUE IS LESS THAN WHEN SHE FIRST GOT THE VACCINE BUT SHE CONTINUES TO FEEL TIRED TO THE POINT WHERE SHE WILL TAKE A NAP.  SHE REFUSES TO GET THE NEXT SHINGRIX VACCINATION.
After second dose of vaccine, woke up with  head to toe hives. Hives became progressively worse over the following 4 weeks. Hives became large bruises /petechiae to  upper thighs. Angioedema to lips, eyes and face.  Tried to relieve the symptoms with anti-histamine's, benadryl , pepcid  and singular.
shortness of breath, wheezing, dizziness the first day she had the vaccines that resolved. also had chills and myalgias for the the day of the vaccines and for the first two days after vaccine administration. continues to have injection site reaction with erythema, tenderness in right upper arm and received the vaccine 3 days ago
Extremely fatigued; Dizzy; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included oral contraceptives (unspecified) for an unknown indication, from an unknown date and unknown if on going. The patient did not receive any other vaccines within four weeks prior to the vaccination. From 17Apr2021, the patient felt extremely fatigued and dizzy every day and it had been 11 days post vaccine at the time of report. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extremely fatigued and dizzy was not resolved at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Large swelling on left ankle; Exhaustion; Headache; Pain in left arm after second dose; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Large swelling on left ankle), FATIGUE (Exhaustion), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in left arm after second dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Thyroiditis and Anxiety.   On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2021, the patient experienced JOINT SWELLING (Large swelling on left ankle). On an unknown date, the patient experienced FATIGUE (Exhaustion), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in left arm after second dose). The patient was treated with Surgery (Surgical removal of large swelling on left ankle) for Joint swelling. At the time of the report, JOINT SWELLING (Large swelling on left ankle) was resolving and FATIGUE (Exhaustion), HEADACHE (Headache) and VACCINATION SITE PAIN (Pain in left arm after second dose) had resolved.            Concomitant medications included blood pressure, thyroid, anxiety medication and took muscle relaxant when needed. No treatment medications were reported. Within 5 to 7 days she developed large swelling on the left ankle which was surgically removed by a podiatrist on 14Oct2021.
Mother c/o bumps coming out on body around 09:45, 15 min afternoon immunizations, epinephrine 1:000 1cc SQ given and Benadryl 0.4cc IM left thigh was given. Vital signs taken and Temperature was98.1, pulse 118, respirations20. NP notified around 0945, Dr notified.
This case was reported by a healthcare professional and described the occurrence of hepatitis b antibody negative in a 49-year-old female subject who was vaccinated with hepatitis B vaccine recombinant (HEPATITIS B vaccine, manufacturer unspecified).  On 16 January 1998, 16 February 1998 and 17 July 1998, the subject received the 1st dose, 2nd dose and 3rd dose of HEPATITIS B vaccine (unknown).  On an unspecified date in August 2008, 10 years after vaccination with HEPATITIS B vaccine, a titer was drawn and the subject was found to be hepatitis b antibody negative.  At the time of reporting, the outcome of the event was unspecified.
Pt began having symptoms of fever, body aches, and fatigue.  Presented to clinic after 3 days with sore throat.
After dinner, indigestion started (which I never get) and progressed into a bad headache that kept worsening overnight. By the next morning, the headache was so severe that my vision was blurry, had tunnel vision, and light sensitivity. Also that morning, I developed a fever to 99.1 degrees, chills, and flu-like body aches. After suffering all day, by about 6pm that night, all symptoms went away and I felt perfectly fine.
Principal Dx/ Final Dx: Acute hypoxemic respiratory failure due to COVID-19   Relevant Inpt Dx: Principal Problem:   Acute hypoxemic respiratory failure due to COVID-19 Active Problems:   HTN (hypertension)   Anemia   End stage renal disease on dialysis   PAF (paroxysmal atrial fibrillation)       HPI:   Hospital Course:   patient was admitted with anemia.  Was seen by GI.  She did not require endoscopy during this admission.     She has esrd and was seen by nephrology for dialysis   She also was seen by cardiology about anticoagulation and PAF.     She has chronic hypoxic respiratory failure and was on oxygen at home.    She had covid in January.  She had worsening of her oxygenation during this stay and was seen by pulmonary.  She progressed to bipap.  CT chest did not show PE.  She continued to struggle with her breathing.  She had decided on DNR status previously and she decided to pursue comfort care.  She expired at  1847
Tongue swollen within 4 hours of dose, I took Tylenol to reduce swelling.
Morning after vaccination, L thigh appeared reddened. It worsened over course of the day. The tissue also became indurated and warm and swollen when I examined her on 10/10/03. Child had no fever, appeared in no sickness. Called mom 12/22/03-symptoms resolved.
After  booster flu shot was given,  a day later child had runny nose, and began itching. No previous cold.  Child has history of exzema.  Exzema was extrely mild at this time. Only region was ankles and under ears. Child became fussy, and exzema  was from head to toe.  Gross amounts on back and head. Also tiny red (pin size) dots were under chin, side of face, arms and small amounts were and still are on anus and on underside of penis and scrotum.  Dots will fade and come back and ezema is still extreme  ( breakage of skin from scratching) This has been going on for 1 and 1/2 weeks.  Administerd the generic form of Atarax, for itching. Lubricate child with over the counter Eurcin cream and a RX cream of Protopic.   1-24 gave child plain scramble egg.  After eating a few bites, child immediately threw up.  Allergies unknown at this time.  2/2/07 Received medical records from provider which real patient experienced thrush & diaper rash & was seen in ER on 1/6/07 for same.  Seen multiple times by PCP for rashes, facial puffiness & blotchiness.  Multiple trips to ER for same.  Multiple Rx w/steroids & Benadryl.  Skin infection 9/25/06.  OM & sinusitis/wheezing & possible pneumonia 12/06.   Continued antibiotics & was dx w/RAD.  Parent provided egg to patient on 1/24 & appears to have worsened eczema.  Continued on oral steroids & provided epi pen.  Counseled on diet restrictions. FINAL DX: allergic reaction to flu vax; allergic reaction most likely to eggs.
This spontaneous report was received from a healthcare professional regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 20-MAY-2016, the patient was vaccinated with improperly stored dose of ROTATEQ lot # L037921 expiration date: 31-MAY-2017 (dose, strength, and route unknown) (incorrect product storage). The vaccine was exposed to temperature of 33.6 Fahrenheit for 12 hours. Data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received shingles vaccine 7 day after getting the Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received shingles vaccine 7 day after getting the Moderna Covid-19 vaccine) in a 55-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received shingles vaccine 7 day after getting the Moderna Covid-19 vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Patient received shingles vaccine 7 day after getting the Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Co-suspect product included non-company product Singles Vaccine for an unknown indication. No concomitant medications were reported No treatment drugs were reported
Patient received ZOSTAVAX vaccine 1-28-11. Called pharmacy to report red splotchy rash had appeared on trunk, arms, then to buttocks. Recommended BENADRYL 25 mg.
COVID arm . I developed a rash on the left arm a week after the injection. It turned red and and there was itching, not terrible but some. It's fading, not as red, still itching.
Period: Heavy bleeding, debilitating cramps, 10 days early, had to stay home from work. Normally: regular intervals in between cycles, light to moderate to light bleeding with little to no cramping. I've never stayed home from work for a period.
Information has been received from a licensed practical nurse concerning a patient (age and gender not reported) who on an unspecified date was vaccinated with a dose of Pneumovax 23 (lot 651357/0391F). Subsequently the patient experienced a reaction after receiving Pneumovax 23. At the time of this report, the outcome was unknown. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot complies with the government agency and was released. Additional information has been requested.
Information has been received from a physician concerning a female who was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot number, injection site and route not reported). Subsequently the patient developed herpes zoster. The patient sought unspecified medical attention. Additional information has been requested.
Information regarding Flumist (2003-2004 Formula)(influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a consumer regarding a female pt who experienced sinusitis and bronchitis.  The pt received a dose on an unspecified date. The pt has a past history of influenza (The pt developed the flu following administration of a "flu shot" 25 years ago).  Indication for Flumist (2003-2004 Formula) was immunization.  Product was administered on an unspecified date.  Dose regimen was 1 dose. Concomitant medications were not reported.  The pt experienced sinusitis (sinusitis) and bronchitis (bronchitis) on an unspecified date.  No additional information was available at the time of this report.
About one week after the shot, I experienced a breakout in hives on my extremities three evenings in a row.    My arms, legs, hands and feet became very itchy.  In the morning the symptoms were gone but returned the next evening.  This lasted just 3 days.
Started with normal type symptoms aches and pains and then by weds had bad headache and by Thursday face become numb and slurred speech. On steroids for 7 days.   Went to neurologist and getting  MRI 4/7/21.   Some improvement.   Numbness now entire face and now spread through hands and legs "feel like jello".
Insomnia- Up all night, severe coughing, difficulty breathing, hoarseness, possible fever-did not take temperature. Took 3 teaspoons of Children's Benadryl Allergy & Sinus.